Vaishali Pharma Limited (VAISHALI) - Total Liabilities

Latest as of September 2025: Rs545.40 Million INR ≈ $5.90 Million USD

Based on the latest financial reports, Vaishali Pharma Limited (VAISHALI) has total liabilities worth Rs545.40 Million INR (≈ $5.90 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how efficiently does Vaishali Pharma Limited generate cash to assess how effectively this company generates cash.

Vaishali Pharma Limited - Total Liabilities Trend (2013–2025)

This chart illustrates how Vaishali Pharma Limited's total liabilities have evolved over time, based on quarterly financial data. Check Vaishali Pharma Limited (VAISHALI) asset resilience to evaluate the company's liquid asset resilience ratio.

Vaishali Pharma Limited Competitors by Total Liabilities

The table below lists competitors of Vaishali Pharma Limited ranked by their total liabilities.

Company Country Total Liabilities
Motio Ltd
AU:MXO
Australia AU$1.67 Million
Arbor Metals Corp
V:ABR
Canada CA$638.58K
HOV Services Limited
NSE:HOVS
India Rs154.74 Million
AB Panevezio Statybos Trestas
STU:YK3
Germany €57.08 Million
Scorpion Minerals Ltd
AU:SCN
Australia AU$1.33 Million
New Nordic Healthbrands AB (publ)
ST:NNH
Sweden Skr152.78 Million
Jatcorp Ltd
AU:JAT
Australia AU$18.64 Million

Liability Composition Analysis (2013–2025)

This chart breaks down Vaishali Pharma Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Vaishali Pharma Limited market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.37 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 0.02 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.81 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.45 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Vaishali Pharma Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Vaishali Pharma Limited (2013–2025)

The table below shows the annual total liabilities of Vaishali Pharma Limited from 2013 to 2025.

Year Total Liabilities Change
2025-03-31 Rs449.29 Million
≈ $4.86 Million
+21.05%
2024-03-31 Rs371.16 Million
≈ $4.01 Million
-3.28%
2023-03-31 Rs383.76 Million
≈ $4.15 Million
-30.57%
2022-03-31 Rs552.70 Million
≈ $5.98 Million
-13.24%
2021-03-31 Rs637.05 Million
≈ $6.89 Million
+42.13%
2020-03-31 Rs448.23 Million
≈ $4.85 Million
-5.34%
2019-03-31 Rs473.52 Million
≈ $5.12 Million
+8.30%
2018-03-31 Rs437.22 Million
≈ $4.73 Million
+7.21%
2017-03-31 Rs407.80 Million
≈ $4.41 Million
-12.34%
2016-03-31 Rs465.19 Million
≈ $5.03 Million
+9.30%
2015-03-31 Rs425.60 Million
≈ $4.60 Million
-15.48%
2014-03-31 Rs503.56 Million
≈ $5.45 Million
+9.93%
2013-03-31 Rs458.09 Million
≈ $4.95 Million
--

About Vaishali Pharma Limited

NSE:VAISHALI India Drug Manufacturers - Specialty & Generic
Market Cap
$10.74 Million
Rs992.82 Million INR
Market Cap Rank
#26712 Global
#1501 in India
Share Price
Rs7.61
Change (1 day)
-4.16%
52-Week Range
Rs4.88 - Rs13.34
All Time High
Rs42.57
About

Vaishali Pharma Limited engages in the pharmaceutical business in India and internationally. It offers a portfolio of active pharmaceutical ingredients, such as antibiotics, anti-ulcer, anti-inflammatory, analgesic, anti-pyretic, topical steroids, anti"malarial, cardiac, corticosteroids, anti-diabetics, anti-cold, anti-allergic, anti-diarrheal, anti-protozoal, anti-parasitic, excipients, anti-vir… Read more